336P PI3K pathway biomarkers and clinical response in a phase I/Ib study of GDC-0077 in hormone receptor-positive/HER2-negative breast cancer (HR+/HER2– BC).

Authors :: Gambardella, V.
Cervantes, A.
Bedard, P.L.
Hamilton, E.P.
Italiano, A.
Jhaveri, K.
Juric, D.
Kalinsky, K.
Krop, I.E.
Oliveira, M.
Saura, C.
Schmid, P.
Turner, N.
Varga, A.
Liu, B.P.
Chen, J.W.
Aimi, J.
Royer-Joo, S.
Schutzman, J.L.
Hutchinson, K.E.
Source :: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS381-S382. 2p.
Publication Year :: 2020

Subjects :: *BREAST cancer
*PHOSPHATIDYLINOSITOL 3-kinases
*BIOMARKERS
*HORMONES

Full Text Access

Tools